nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazepam—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.161	1	CbGbCtD
Diazepam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0124	0.0599	CbGeAlD
Diazepam—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0117	0.026	CcSEcCtD
Diazepam—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.0117	0.026	CcSEcCtD
Diazepam—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0117	0.026	CcSEcCtD
Diazepam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0107	0.0519	CbGeAlD
Diazepam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.0103	0.05	CbGeAlD
Diazepam—GABRQ—nerve—amyotrophic lateral sclerosis	0.00964	0.0467	CbGeAlD
Diazepam—GABRR3—nerve—amyotrophic lateral sclerosis	0.00964	0.0467	CbGeAlD
Diazepam—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00927	0.0206	CcSEcCtD
Diazepam—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00874	0.0194	CcSEcCtD
Diazepam—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0192	CcSEcCtD
Diazepam—GABRR2—nerve—amyotrophic lateral sclerosis	0.00835	0.0405	CbGeAlD
Diazepam—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00827	0.0184	CcSEcCtD
Diazepam—GABRR1—nerve—amyotrophic lateral sclerosis	0.00804	0.039	CbGeAlD
Diazepam—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00795	0.0177	CcSEcCtD
Diazepam—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0175	CcSEcCtD
Diazepam—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0173	CcSEcCtD
Diazepam—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0173	CcSEcCtD
Diazepam—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0159	CcSEcCtD
Diazepam—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00692	0.0154	CcSEcCtD
Diazepam—TSPO—hindlimb—amyotrophic lateral sclerosis	0.00685	0.0332	CbGeAlD
Diazepam—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00685	0.0152	CcSEcCtD
Diazepam—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0143	CcSEcCtD
Diazepam—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0141	CcSEcCtD
Diazepam—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0138	CcSEcCtD
Diazepam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00614	0.0137	CcSEcCtD
Diazepam—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00614	0.0137	CcSEcCtD
Diazepam—TSPO—appendage—amyotrophic lateral sclerosis	0.00588	0.0285	CbGeAlD
Diazepam—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00583	0.013	CcSEcCtD
Diazepam—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00578	0.0128	CcSEcCtD
Diazepam—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00578	0.0128	CcSEcCtD
Diazepam—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0125	CcSEcCtD
Diazepam—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0109	CcSEcCtD
Diazepam—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0106	CcSEcCtD
Diazepam—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0106	CcSEcCtD
Diazepam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0046	0.0102	CcSEcCtD
Diazepam—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00985	CcSEcCtD
Diazepam—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00985	CcSEcCtD
Diazepam—Mazindol—SIGMAR1—amyotrophic lateral sclerosis	0.0044	0.481	CrCbGaD
Diazepam—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00967	CcSEcCtD
Diazepam—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00961	CcSEcCtD
Diazepam—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00934	CcSEcCtD
Diazepam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00934	CcSEcCtD
Diazepam—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00874	CcSEcCtD
Diazepam—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00839	CcSEcCtD
Diazepam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00831	CcSEcCtD
Diazepam—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00823	CcSEcCtD
Diazepam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00369	0.0179	CbGeAlD
Diazepam—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00815	CcSEcCtD
Diazepam—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00803	CcSEcCtD
Diazepam—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00799	CcSEcCtD
Diazepam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00352	0.385	CrCbGaD
Diazepam—Injury—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00764	CcSEcCtD
Diazepam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00337	0.0163	CbGeAlD
Diazepam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00747	CcSEcCtD
Diazepam—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00747	CcSEcCtD
Diazepam—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00744	CcSEcCtD
Diazepam—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00738	CcSEcCtD
Diazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00326	0.0158	CbGeAlD
Diazepam—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00719	CcSEcCtD
Diazepam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00702	CcSEcCtD
Diazepam—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00702	CcSEcCtD
Diazepam—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00696	CcSEcCtD
Diazepam—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00691	CcSEcCtD
Diazepam—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00686	CcSEcCtD
Diazepam—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.003	0.00668	CcSEcCtD
Diazepam—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.003	0.00668	CcSEcCtD
Diazepam—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00665	CcSEcCtD
Diazepam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0066	CcSEcCtD
Diazepam—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00653	CcSEcCtD
Diazepam—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00641	CcSEcCtD
Diazepam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00619	CcSEcCtD
Diazepam—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00607	CcSEcCtD
Diazepam—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00607	CcSEcCtD
Diazepam—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00567	CcSEcCtD
Diazepam—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00567	CcSEcCtD
Diazepam—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00559	CcSEcCtD
Diazepam—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00554	CcSEcCtD
Diazepam—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00544	CcSEcCtD
Diazepam—Depression—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00539	CcSEcCtD
Diazepam—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00533	CcSEcCtD
Diazepam—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0053	CcSEcCtD
Diazepam—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00527	CcSEcCtD
Diazepam—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00526	CcSEcCtD
Diazepam—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00519	CcSEcCtD
Diazepam—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00512	CcSEcCtD
Diazepam—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00508	CcSEcCtD
Diazepam—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00505	CcSEcCtD
Diazepam—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00494	CcSEcCtD
Diazepam—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00487	CcSEcCtD
Diazepam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00483	CcSEcCtD
Diazepam—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00483	CcSEcCtD
Diazepam—GABRQ—nervous system—amyotrophic lateral sclerosis	0.00217	0.0105	CbGeAlD
Diazepam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00217	0.0105	CbGeAlD
Diazepam—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0048	CcSEcCtD
Diazepam—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00478	CcSEcCtD
Diazepam—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00476	CcSEcCtD
Diazepam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00211	0.0102	CbGeAlD
Diazepam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00209	0.0101	CbGeAlD
Diazepam—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.00209	0.0101	CbGeAlD
Diazepam—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00454	CcSEcCtD
Diazepam—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00451	CcSEcCtD
Diazepam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00201	0.00976	CbGeAlD
Diazepam—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00441	CcSEcCtD
Diazepam—Chills—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00436	CcSEcCtD
Diazepam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00195	0.00946	CbGeAlD
Diazepam—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00434	CcSEcCtD
Diazepam—TSPO—embryo—amyotrophic lateral sclerosis	0.00195	0.00945	CbGeAlD
Diazepam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00193	0.00936	CbGeAlD
Diazepam—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00425	CcSEcCtD
Diazepam—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00423	CcSEcCtD
Diazepam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.0019	0.0092	CbGeAlD
Diazepam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00188	0.00911	CbGeAlD
Diazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00187	0.00904	CbGeAlD
Diazepam—Tension—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00415	CcSEcCtD
Diazepam—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00414	CcSEcCtD
Diazepam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00411	CcSEcCtD
Diazepam—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00409	CcSEcCtD
Diazepam—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00406	CcSEcCtD
Diazepam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00183	0.00886	CbGeAlD
Diazepam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00181	0.00876	CbGeAlD
Diazepam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.0018	0.0087	CbGeAlD
Diazepam—TSPO—brainstem—amyotrophic lateral sclerosis	0.00179	0.00866	CbGeAlD
Diazepam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00177	0.00857	CbGeAlD
Diazepam—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00391	CcSEcCtD
Diazepam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00389	CcSEcCtD
Diazepam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00174	0.00844	CbGeAlD
Diazepam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00174	0.00844	CbGeAlD
Diazepam—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0038	CcSEcCtD
Diazepam—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00379	CcSEcCtD
Diazepam—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00378	CcSEcCtD
Diazepam—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00374	CcSEcCtD
Diazepam—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00372	CcSEcCtD
Diazepam—Cough—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00369	CcSEcCtD
Diazepam—GABRQ—brain—amyotrophic lateral sclerosis	0.00166	0.00803	CbGeAlD
Diazepam—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0036	CcSEcCtD
Diazepam—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0036	CcSEcCtD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00357	CcSEcCtD
Diazepam—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00356	CcSEcCtD
Diazepam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00352	CcSEcCtD
Diazepam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00157	0.00762	CbGeAlD
Diazepam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00348	CcSEcCtD
Diazepam—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00345	CcSEcCtD
Diazepam—Infection—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00343	CcSEcCtD
Diazepam—Shock—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00339	CcSEcCtD
Diazepam—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00338	CcSEcCtD
Diazepam—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00338	CcSEcCtD
Diazepam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00337	CcSEcCtD
Diazepam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00151	0.00733	CbGeAlD
Diazepam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00151	0.00733	CbGeAlD
Diazepam—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00335	CcSEcCtD
Diazepam—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00334	CcSEcCtD
Diazepam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00148	0.00717	CbGeAlD
Diazepam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00329	CcSEcCtD
Diazepam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00147	0.00714	CbGeAlD
Diazepam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00147	0.00714	CbGeAlD
Diazepam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00147	0.00711	CbGeAlD
Diazepam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00146	0.00707	CbGeAlD
Diazepam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00706	CbGeAlD
Diazepam—GABRG3—brain—amyotrophic lateral sclerosis	0.00145	0.00703	CbGeAlD
Diazepam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00322	CcSEcCtD
Diazepam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00142	0.0069	CbGeAlD
Diazepam—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00314	CcSEcCtD
Diazepam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00684	CbGeAlD
Diazepam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00681	CbGeAlD
Diazepam—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00312	CcSEcCtD
Diazepam—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0031	CcSEcCtD
Diazepam—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00308	CcSEcCtD
Diazepam—GABRR1—brain—amyotrophic lateral sclerosis	0.00138	0.0067	CbGeAlD
Diazepam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00138	0.00669	CbGeAlD
Diazepam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00307	CcSEcCtD
Diazepam—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00304	CcSEcCtD
Diazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00136	0.00658	CbGeAlD
Diazepam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00135	0.003	CcSEcCtD
Diazepam—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00298	CcSEcCtD
Diazepam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00297	CcSEcCtD
Diazepam—Pain—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00295	CcSEcCtD
Diazepam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00295	CcSEcCtD
Diazepam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00131	0.00637	CbGeAlD
Diazepam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00131	0.00637	CbGeAlD
Diazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00131	0.00634	CbGeAlD
Diazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.0013	0.00631	CbGeAlD
Diazepam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00284	CcSEcCtD
Diazepam—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00282	CcSEcCtD
Diazepam—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.00125	0.00604	CbGeAlD
Diazepam—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00274	CcSEcCtD
Diazepam—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00273	CcSEcCtD
Diazepam—GABRD—brain—amyotrophic lateral sclerosis	0.0012	0.00582	CbGeAlD
Diazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00116	0.00562	CbGeAlD
Diazepam—GABRG1—brain—amyotrophic lateral sclerosis	0.00116	0.0056	CbGeAlD
Diazepam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00254	CcSEcCtD
Diazepam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00113	0.00548	CbGeAlD
Diazepam—GABRB1—brain—amyotrophic lateral sclerosis	0.00112	0.00543	CbGeAlD
Diazepam—GABRA5—brain—amyotrophic lateral sclerosis	0.00112	0.00541	CbGeAlD
Diazepam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00248	CcSEcCtD
Diazepam—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00111	0.00539	CbGeAlD
Diazepam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00111	0.00537	CbGeAlD
Diazepam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00111	0.00537	CbGeAlD
Diazepam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00244	CcSEcCtD
Diazepam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00517	CbGeAlD
Diazepam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00517	CbGeAlD
Diazepam—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00236	CcSEcCtD
Diazepam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00104	0.00505	CbGeAlD
Diazepam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00104	0.00505	CbGeAlD
Diazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00104	0.00503	CbGeAlD
Diazepam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00228	CcSEcCtD
Diazepam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00101	0.0049	CbGeAlD
Diazepam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00101	0.00489	CbGeAlD
Diazepam—GABRE—nervous system—amyotrophic lateral sclerosis	0.001	0.00486	CbGeAlD
Diazepam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00219	CcSEcCtD
Diazepam—Rash—Riluzole—amyotrophic lateral sclerosis	0.000978	0.00218	CcSEcCtD
Diazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000978	0.00474	CbGeAlD
Diazepam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00217	CcSEcCtD
Diazepam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.000974	0.00472	CbGeAlD
Diazepam—Headache—Riluzole—amyotrophic lateral sclerosis	0.000972	0.00216	CcSEcCtD
Diazepam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.000966	0.00468	CbGeAlD
Diazepam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.000952	0.00461	CbGeAlD
Diazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000941	0.00456	CbGeAlD
Diazepam—TSPO—nervous system—amyotrophic lateral sclerosis	0.000937	0.00454	CbGeAlD
Diazepam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000922	0.00205	CcSEcCtD
Diazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00092	0.00446	CbGeAlD
Diazepam—TSPO—central nervous system—amyotrophic lateral sclerosis	0.000902	0.00437	CbGeAlD
Diazepam—TSPO—cerebellum—amyotrophic lateral sclerosis	0.000881	0.00427	CbGeAlD
Diazepam—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.000856	0.0936	CrCbGaD
Diazepam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00085	0.00412	CbGeAlD
Diazepam—GABRB2—brain—amyotrophic lateral sclerosis	0.000847	0.0041	CbGeAlD
Diazepam—GABRG2—brain—amyotrophic lateral sclerosis	0.000847	0.0041	CbGeAlD
Diazepam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.000819	0.00397	CbGeAlD
Diazepam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.0008	0.00388	CbGeAlD
Diazepam—GABRA2—brain—amyotrophic lateral sclerosis	0.000773	0.00375	CbGeAlD
Diazepam—GABRE—brain—amyotrophic lateral sclerosis	0.000767	0.00372	CbGeAlD
Diazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.000747	0.00362	CbGeAlD
Diazepam—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00072	0.00349	CbGeAlD
Diazepam—TSPO—brain—amyotrophic lateral sclerosis	0.000716	0.00347	CbGeAlD
Diazepam—ALB—brain—amyotrophic lateral sclerosis	0.000699	0.00339	CbGeAlD
Diazepam—GABRB3—brain—amyotrophic lateral sclerosis	0.00065	0.00315	CbGeAlD
Diazepam—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000642	0.00311	CbGeAlD
Diazepam—ABCB1—embryo—amyotrophic lateral sclerosis	0.000642	0.00311	CbGeAlD
Diazepam—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000619	0.003	CbGeAlD
Diazepam—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000577	0.00279	CbGeAlD
Diazepam—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000555	0.00269	CbGeAlD
Diazepam—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000541	0.00262	CbGeAlD
Diazepam—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000521	0.00253	CbGeAlD
Diazepam—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000521	0.00252	CbGeAlD
Diazepam—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000509	0.00247	CbGeAlD
Diazepam—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000502	0.00243	CbGeAlD
Diazepam—CYP2C8—brain—amyotrophic lateral sclerosis	0.000491	0.00238	CbGeAlD
Diazepam—CYP2B6—brain—amyotrophic lateral sclerosis	0.000441	0.00214	CbGeAlD
Diazepam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000435	0.00211	CbGeAlD
Diazepam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000419	0.00203	CbGeAlD
Diazepam—CYP2E1—brain—amyotrophic lateral sclerosis	0.000414	0.002	CbGeAlD
Diazepam—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00041	0.00199	CbGeAlD
Diazepam—PTGS1—brain—amyotrophic lateral sclerosis	0.000398	0.00193	CbGeAlD
Diazepam—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.000367	0.0401	CrCbGaD
Diazepam—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000366	0.00177	CbGeAlD
Diazepam—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000308	0.00149	CbGeAlD
Diazepam—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000297	0.00144	CbGeAlD
Diazepam—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00029	0.00141	CbGeAlD
Diazepam—ABCB1—brain—amyotrophic lateral sclerosis	0.000236	0.00114	CbGeAlD
Diazepam—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000113	0.000649	CbGpPWpGaD
Diazepam—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000646	CbGpPWpGaD
Diazepam—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000644	CbGpPWpGaD
Diazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000111	0.000641	CbGpPWpGaD
Diazepam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.00011	0.000635	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00011	0.000634	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00011	0.000633	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000109	0.000626	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000107	0.000619	CbGpPWpGaD
Diazepam—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000107	0.000618	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000107	0.000614	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000106	0.000611	CbGpPWpGaD
Diazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000103	0.000595	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000102	0.000589	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000102	0.000586	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.99e-05	0.000576	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.9e-05	0.000571	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	9.9e-05	0.000571	CbGpPWpGaD
Diazepam—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.82e-05	0.000566	CbGpPWpGaD
Diazepam—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	9.69e-05	0.000559	CbGpPWpGaD
Diazepam—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.68e-05	0.000558	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	9.61e-05	0.000554	CbGpPWpGaD
Diazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.5e-05	0.000548	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.39e-05	0.000541	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.31e-05	0.000537	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.26e-05	0.000533	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.2e-05	0.00053	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	9.14e-05	0.000527	CbGpPWpGaD
Diazepam—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	9.01e-05	0.000519	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	8.98e-05	0.000518	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	8.89e-05	0.000512	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	8.89e-05	0.000512	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.87e-05	0.000511	CbGpPWpGaD
Diazepam—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.76e-05	0.000505	CbGpPWpGaD
Diazepam—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	8.73e-05	0.000503	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	8.7e-05	0.000502	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	8.7e-05	0.000502	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	8.69e-05	0.000501	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	8.69e-05	0.000501	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	8.69e-05	0.000501	CbGpPWpGaD
Diazepam—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	8.64e-05	0.000498	CbGpPWpGaD
Diazepam—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.64e-05	0.000498	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	8.42e-05	0.000485	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.26e-05	0.000476	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	8.18e-05	0.000472	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	8.13e-05	0.000468	CbGpPWpGaD
Diazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	8e-05	0.000461	CbGpPWpGaD
Diazepam—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.99e-05	0.000461	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.96e-05	0.000459	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	7.94e-05	0.000458	CbGpPWpGaD
Diazepam—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.88e-05	0.000454	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.8e-05	0.00045	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	7.66e-05	0.000442	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	7.57e-05	0.000436	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.56e-05	0.000436	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.53e-05	0.000434	CbGpPWpGaD
Diazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.52e-05	0.000434	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	7.52e-05	0.000434	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	7.52e-05	0.000434	CbGpPWpGaD
Diazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	7.51e-05	0.000433	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	7.51e-05	0.000433	CbGpPWpGaD
Diazepam—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	7.48e-05	0.000431	CbGpPWpGaD
Diazepam—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	7.48e-05	0.000431	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.4e-05	0.000427	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.39e-05	0.000426	CbGpPWpGaD
Diazepam—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	7.35e-05	0.000424	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	7.34e-05	0.000423	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	7.23e-05	0.000417	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	7.1e-05	0.000409	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.01e-05	0.000404	CbGpPWpGaD
Diazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	7e-05	0.000404	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.97e-05	0.000402	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.96e-05	0.000401	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	6.94e-05	0.0004	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	6.88e-05	0.000397	CbGpPWpGaD
Diazepam—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	6.84e-05	0.000394	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.83e-05	0.000394	CbGpPWpGaD
Diazepam—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.83e-05	0.000394	CbGpPWpGaD
Diazepam—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.73e-05	0.000388	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	6.71e-05	0.000387	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	6.71e-05	0.000387	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.63e-05	0.000382	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.63e-05	0.000382	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	6.58e-05	0.000379	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	6.55e-05	0.000378	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	6.55e-05	0.000378	CbGpPWpGaD
Diazepam—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	6.5e-05	0.000375	CbGpPWpGaD
Diazepam—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	6.48e-05	0.000373	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.44e-05	0.000371	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	6.42e-05	0.00037	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.4e-05	0.000369	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.38e-05	0.000368	CbGpPWpGaD
Diazepam—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.36e-05	0.000367	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	6.29e-05	0.000363	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	6.28e-05	0.000362	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.26e-05	0.000361	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	6.14e-05	0.000354	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	6.12e-05	0.000353	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	6.12e-05	0.000353	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	6.08e-05	0.00035	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	6.01e-05	0.000347	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.99e-05	0.000346	CbGpPWpGaD
Diazepam—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	5.98e-05	0.000345	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.91e-05	0.000341	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	5.89e-05	0.000339	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.81e-05	0.000335	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.81e-05	0.000335	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.71e-05	0.000329	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.71e-05	0.000329	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	5.6e-05	0.000323	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.57e-05	0.000321	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	5.44e-05	0.000314	CbGpPWpGaD
Diazepam—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	5.41e-05	0.000312	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	5.37e-05	0.000309	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.36e-05	0.000309	CbGpPWpGaD
Diazepam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.27e-05	0.000304	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.24e-05	0.000302	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	5.23e-05	0.000302	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	5.23e-05	0.000302	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.21e-05	0.0003	CbGpPWpGaD
Diazepam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.2e-05	0.0003	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.18e-05	0.000299	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	4.99e-05	0.000288	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	4.99e-05	0.000288	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.91e-05	0.000283	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.89e-05	0.000282	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.88e-05	0.000281	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.87e-05	0.000281	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	4.85e-05	0.00028	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.84e-05	0.000279	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.79e-05	0.000276	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.77e-05	0.000275	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	4.76e-05	0.000274	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	4.74e-05	0.000273	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	4.49e-05	0.000259	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.45e-05	0.000256	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	4.43e-05	0.000255	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.41e-05	0.000254	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	4.4e-05	0.000254	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	4.39e-05	0.000253	CbGpPWpGaD
Diazepam—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.22e-05	0.000243	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.18e-05	0.000241	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	4.12e-05	0.000238	CbGpPWpGaD
Diazepam—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.1e-05	0.000236	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	4.07e-05	0.000235	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.04e-05	0.000233	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.04e-05	0.000233	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.03e-05	0.000232	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	3.8e-05	0.000219	CbGpPWpGaD
Diazepam—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.78e-05	0.000218	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.78e-05	0.000218	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.78e-05	0.000218	CbGpPWpGaD
Diazepam—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.78e-05	0.000218	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.71e-05	0.000214	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.69e-05	0.000213	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.69e-05	0.000213	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	3.68e-05	0.000212	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.61e-05	0.000208	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	3.61e-05	0.000208	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.59e-05	0.000207	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.46e-05	0.0002	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.44e-05	0.000199	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.43e-05	0.000198	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	3.4e-05	0.000196	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.35e-05	0.000193	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	3.31e-05	0.000191	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.26e-05	0.000188	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.23e-05	0.000186	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.21e-05	0.000185	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	3.12e-05	0.00018	CbGpPWpGaD
Diazepam—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.11e-05	0.000179	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.1e-05	0.000178	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.09e-05	0.000178	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	3.05e-05	0.000176	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.02e-05	0.000174	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.92e-05	0.000168	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.87e-05	0.000165	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.85e-05	0.000164	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.83e-05	0.000163	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.82e-05	0.000163	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.79e-05	0.000161	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.72e-05	0.000157	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.68e-05	0.000155	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.65e-05	0.000152	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.6e-05	0.00015	CbGpPWpGaD
Diazepam—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.57e-05	0.000148	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.54e-05	0.000147	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.54e-05	0.000147	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000142	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.43e-05	0.00014	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.41e-05	0.000139	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.39e-05	0.000138	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.32e-05	0.000134	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.21e-05	0.000128	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.17e-05	0.000125	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.09e-05	0.00012	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.04e-05	0.000118	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	2.03e-05	0.000117	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.98e-05	0.000114	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.98e-05	0.000114	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	1.97e-05	0.000113	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.95e-05	0.000113	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.000112	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.94e-05	0.000112	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.000112	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.82e-05	0.000105	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.78e-05	0.000103	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.78e-05	0.000103	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.74e-05	0.0001	CbGpPWpGaD
Diazepam—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.68e-05	9.68e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.68e-05	9.68e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.68e-05	9.66e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.67e-05	9.62e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.59e-05	9.16e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.54e-05	8.89e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	8.84e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.5e-05	8.64e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	8.64e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.47e-05	8.47e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.47e-05	8.45e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.46e-05	8.43e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-05	8.01e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	7.94e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.37e-05	7.88e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.36e-05	7.83e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.35e-05	7.76e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	7.75e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.27e-05	7.32e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.27e-05	7.32e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-05	7.28e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.26e-05	7.24e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	6.73e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.13e-05	6.53e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.11e-05	6.37e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	6.18e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	5.95e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.03e-05	5.92e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.01e-05	5.8e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1e-05	5.79e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.01e-06	5.19e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.83e-06	5.09e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.7e-06	5.01e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.65e-06	4.98e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.28e-06	4.77e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.76e-06	4.47e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.58e-06	4.37e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.08e-06	4.08e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.81e-06	3.93e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.05e-06	3.49e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.67e-06	2.69e-05	CbGpPWpGaD
